|
SHQ1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.288000E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.399800E-01 |
| Normal-vs-Stage2 |
2.462600E-01 |
| Normal-vs-Stage3 |
4.017000E-01 |
| Normal-vs-Stage4 |
3.837900E-02 |
| Stage1-vs-Stage2 |
4.713400E-01 |
| Stage1-vs-Stage3 |
7.245000E-01 |
| Stage1-vs-Stage4 |
1.649220E-01 |
| Stage2-vs-Stage3 |
8.070400E-01 |
| Stage2-vs-Stage4 |
6.446000E-01 |
| Stage3-vs-Stage4 |
5.420400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.220200E-01 |
| Normal-vs-AfricanAmerican |
9.410800E-01 |
| Normal-vs-Asian |
6.866000E-01 |
| Caucasian-vs-AfricanAmerican |
6.514800E-01 |
| Caucasian-vs-Asian |
9.656800E-01 |
| AfricanAmerican-vs-Asian |
9.042800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.013700E-02 |
| Normal-vs-Female |
7.365500E-02 |
| Male-vs-Female |
2.819000E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.906600E-01 |
| Normal-vs-Extreme_Weight |
9.222000E-02 |
| Normal-vs-Obese |
5.416200E-01 |
| Normal-vs-Extreme_Obese |
5.003000E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.294200E-01 |
| Normal_Weight-vs-Obese |
9.173800E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.264400E-01 |
| Extreme_Weight-vs-Obese |
4.145800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.581600E-01 |
| Obese-vs-Extreme_Obese |
6.601800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.996430E-01 |
| Normal-vs-Age(41-60Yrs) |
7.565600E-01 |
| Normal-vs-Age(61-80Yrs) |
1.154430E-01 |
| Normal-vs-Age(81-100Yrs) |
5.823300E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.996200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.108630E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.577800E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.020550E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.444210E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.884800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.225400E-01 |
| Normal-VS-Type2 PRCC |
1.862220E-01 |
| Normal-VS-KIRP CIMP |
2.843200E-01 |
| Normal-VS-Unclassified PRCC |
9.519800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.725800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.102200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.072800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.218200E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
3.250600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.075200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.521600E-03 |
| Normal-vs-N1 |
6.012200E-01 |
| Normal-vs-N2 |
1.819400E-03 |
| N0-vs-N1 |
1.568560E-01 |
| N0-vs-N2 |
3.013200E-01 |
| N1-vs-N2 |
7.621700E-02 |
|
|
